Automated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD
O2MATIC
1 other identifier
interventional
20
1 country
2
Brief Summary
The aim of the study is to examine if automated oxygen delivery with O2matic is better than manually controlled oxygen therapy for patients admitted to hospital with an exacerbation in Chronic Obstructive Pulmonary Disease (COPD). O2matic is a closed -loop system based on continuous non-invasive measurement of pulse and oxygen-saturation that is processed in an algorithm that controls the flow of oxygen to the patient. The primary hypothesis is that O2matic increases time within acceptable oxygen-saturation interval. Secondary hypotheses are that O2matic compared to manual control reduces time with severe hypoxia (SpO2 \< 85 %), hypoxi (SpO2 below intended interval) and hyperoxia (SpO2 above intended interval).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2018
CompletedFirst Posted
Study publicly available on registry
March 14, 2018
CompletedStudy Start
First participant enrolled
May 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 8, 2018
CompletedJanuary 8, 2019
January 1, 2019
3 months
March 2, 2018
January 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time within SpO2-interval
Fraction of time where SpO2 is kept within desired interval (e.g. 88-92 %) relative to time with SpO2-signal.
4 hours
Secondary Outcomes (3)
Time with severe hypoxia
4 hours
Time with hypoxia
4 hours
Time with hyperoxia
4 hours
Study Arms (2)
O2matic
ACTIVE COMPARATOROxygen administered by O2matic. Automatic adjustment based on continuous measurement of SpO2.
Manual
NO INTERVENTIONOxygen administered by manual control based on nurse's intermittent measurement of SpO2.
Interventions
Continous measurement of SpO2 during an admission with COPD, and closed-loop control of oxygen-delivery to maintain SpO2 within a target interval.
Eligibility Criteria
You may qualify if:
- COPD verified by FEV1/FVC \< 0,70
- Admission due to exacerbation in COPD
- COPD exacerbation and pneumonia can be included
- Duration of admission \> 48 hours
- Cognitively able to participate in the study
- Willing to participate and give informed consent.
You may not qualify if:
- Need or anticipated need for mechanical ventilation (except intermittent CPAP)
- Major co-morbidities (cancer, heart disease, thromboembolic disease, uncontrolled diabetes)
- Asthma or other respiratory condition requiring higher SpO2 than normal for COPD- patients
- Pregnancy
- Acute thromboembolic disease (\< 2 weeks)
- Cognitive barriers for participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hvidovre University Hospitallead
- Innovation Fund Denmarkcollaborator
Study Sites (2)
Gentofte University Hospital
Hellerup, 2900, Denmark
Hvidovre University Hospital
Hvidovre, 2650, Denmark
Related Publications (7)
Claure N, Bancalari E. Closed-loop control of inspired oxygen in premature infants. Semin Fetal Neonatal Med. 2015 Jun;20(3):198-204. doi: 10.1016/j.siny.2015.02.003. Epub 2015 Mar 12.
PMID: 25773271BACKGROUNDJohannigman JA, Branson R, Lecroy D, Beck G. Autonomous control of inspired oxygen concentration during mechanical ventilation of the critically injured trauma patient. J Trauma. 2009 Feb;66(2):386-92. doi: 10.1097/TA.0b013e318197a4bb.
PMID: 19204511BACKGROUNDL'Her E, Dias P, Gouillou M, Riou A, Souquiere L, Paleiron N, Archambault P, Bouchard PA, Lellouche F. Automatic versus manual oxygen administration in the emergency department. Eur Respir J. 2017 Jul 20;50(1):1602552. doi: 10.1183/13993003.02552-2016. Print 2017 Jul.
PMID: 28729473BACKGROUNDLellouche F, Bouchard PA, Roberge M, Simard S, L'Her E, Maltais F, Lacasse Y. Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial. Int J Chron Obstruct Pulmon Dis. 2016 Aug 24;11:1983-90. doi: 10.2147/COPD.S112820. eCollection 2016.
PMID: 27601891BACKGROUNDLellouche F, L'Her E, Bouchard PA, Brouillard C, Maltais F. Automatic Oxygen Titration During Walking in Subjects With COPD: A Randomized Crossover Controlled Study. Respir Care. 2016 Nov;61(11):1456-1464. doi: 10.4187/respcare.04406. Epub 2016 Oct 18.
PMID: 27794080BACKGROUNDRice KL, Schmidt MF, Buan JS, Lebahn F, Schwarzock TK. AccuO2 oximetry-driven oxygen-conserving device versus fixed-dose oxygen devices in stable COPD patients. Respir Care. 2011 Dec;56(12):1901-5.
PMID: 22288082BACKGROUNDHansen EF, Hove JD, Bech CS, Jensen JS, Kallemose T, Vestbo J. Automated oxygen control with O2matic(R) during admission with exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2018 Dec 14;13:3997-4003. doi: 10.2147/COPD.S183762. eCollection 2018.
PMID: 30587955RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jørgen Vestbo, DMSc
Manchester University Hospital
- PRINCIPAL INVESTIGATOR
Ejvind Frausing Hansen, MD
Hvidovre University Hospital, Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
March 2, 2018
First Posted
March 14, 2018
Study Start
May 7, 2018
Primary Completion
August 8, 2018
Study Completion
August 8, 2018
Last Updated
January 8, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share